Your search returned 64806 results.

Results
	1.	Response to letter to the Editors-Safety of long-term denosumab therapy. [electronic resource] by Stopeck, Alison T Warner, Douglas J Producer: 20180312 In: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Change in Bone Mineral Density Is an Indicator of Treatment-Related Antifracture Effect. [electronic resource] by Bell, Katy J L Hayen, Andrew Glasziou, Paul Irwig, Les Bauer, Douglas C Producer: 20171208 In: Annals of internal medicine vol. 166 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Change in Bone Mineral Density Is an Indicator of Treatment-Related Antifracture Effect. [electronic resource] by Leslie, William D Majumdar, Sumit R Morin, Suzanne N Lix, Lisa M Producer: 20171208 In: Annals of internal medicine vol. 166 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Full 24-month treatment course with daily teriparatide: a mechanistic insight. [electronic resource] by Sugiyama, T Kono, Y Sekiguchi, K Kim, Y T Oda, H Producer: 20180515 In: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Letter to the editor in response to the commentary, "Concurrent administration of PTH and antiresorptives: Additive effects or DXA cosmetics. [electronic resource] by Leder, Benjamin Z Tsai, Joy N Burnett-Bowie, Sherri-Anne Bouxsein, Mary L Neer, Robert M Producer: 20171225 In: Bone vol. 89 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Bisphosphonate drug holidays. [electronic resource] by Nayak, S Greenspan, S L Producer: 20200219 In: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Letter to the Editor: "Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis". [electronic resource] by Sugiyama, Toshihiro Producer: 20181220 In: The Journal of clinical endocrinology and metabolism vol. 103 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Osteoporosis: to treat or not to treat? [electronic resource] by Talla, Maria Rita Gallacher, Stephen J Producer: 20210728 In: Age and ageing vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Safety of long-term denosumab therapy for osteoporosis. [electronic resource] by Compston, Juliet Producer: 20180423 In: The lancet. Diabetes & endocrinology vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Is Atypical Bisphosphonate Treatment Response a Risk Factor for Atypical Femoral Fracture?: Commentary on an article by Kyung-Jae Lee, MD, et al.: "T-Score Discordance of Bone Mineral Density in Patients with Atypical Femoral Fracture". [electronic resource] by Troy, Karen L Producer: 20190322 In: The Journal of bone and joint surgery. American volume vol. 99 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Response to letter to the editor by Leder et al. regarding commentary "Concurrent administration of PTH and antiresorptives: Additive effects or DXA cosmetics". [electronic resource] by Eriksen, Erik Fink Brown, Jacques P Producer: 20171225 In: Bone vol. 89 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	[The new concept for the diagnosis of osteoporosis]. [electronic resource] by Soen, Satoshi Producer: 20160201 In: Nihon rinsho. Japanese journal of clinical medicine vol. 73 Availability: No items available. Save to lists Add to cart (remove)
	13.	ANABOLIC BONE WINDOW WITH WEEKLY TERIPARATIDE THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS. [electronic resource] by Abate, Ejigayehu G Producer: 20170922 In: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Bisphosphonates Can Maintain Periprosthetic Bone Mass Density after Total Hip Replacement, with Controversy in Region of Interest 5. [electronic resource] by Hao, Dongsheng Wang, Junjie Zuo, Liyun Producer: 20210319 In: Current pharmaceutical design vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	[Secondary osteoporosis. Disease-Related Osteoporosis in Children.] [electronic resource] by Michigami, Toshimi Producer: 20190507 In: Clinical calcium vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Osteoporosis in men. [electronic resource] by Khosla, Sundeep Amin, Shreyasee Orwoll, Eric Producer: 20080731 In: Endocrine reviews vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Letter to the Editor: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid. [electronic resource] by Makras, Polyzois Polyzos, Stergios A Anastasilakis, Athanasios D Producer: 20180507 In: The Journal of clinical endocrinology and metabolism vol. 101 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Response to the Letter: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid. [electronic resource] by Miller, Paul D Pannacciulli, Nico Wagman, Rachel B Cummings, Steven R Producer: 20180507 In: The Journal of clinical endocrinology and metabolism vol. 101 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Alendronate and Hip Fracture in Patients Using Glucocorticoids. [electronic resource] by Desai, Rishi J Franklin, Jessica M Kim, Seoyoung C Producer: 20171113 In: JAMA vol. 318 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Alendronate and Hip Fracture in Patients Using Glucocorticoids-Reply. [electronic resource] by Axelsson, Kristian F Nilsson, Anna G Lorentzon, Mattias Producer: 20171113 In: JAMA vol. 318 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

1
2
3
4
5
6
7
8
9
10
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 64806 results.